Institutional
BML Capital Management, LLC
CIK 0001616824
$155.8M
Reported AUM
16
Positions
Q1 2026
Period
2026-05-06
Filed
The Brief · BML Capital Management, LLC · Q1 2026
AI · grounded in 13F
BML Capital Management, LLC established a new position in TLYS valued at $8.7M. The fund also opened new stakes in KHC for $2.8M and JANX for $2.1M. To fund these moves, the manager closed positions in CVNA with a $2.0M reduction, as well as TSLA and LSTA. Additionally, the fund increased its holding in OM by 250.2%.
Portfolio · Q1 2026
Top holdings
QoQ vs Q4 2025
| # | Stock | Issuer | Price | Day % | 1Y Gr. | 5Y Gr. | Value | % of book | Δ shares (QoQ) | Status |
|---|---|---|---|---|---|---|---|---|---|---|
| 1 | ACRS | ACLARIS THERAPEUTICS INC | $4.32 | -1.14% | 193.88% | -71.06% | $53.4M | 34.31% | — | HELD |
| 2 | AVIR | ATEA PHARMACEUTICALS INC | $4.49 | 2.98% | 42.09% | -82.07% | $38.0M | 24.38% | −431,343 | −5.8% |
| 3 | ORMP | ORAMED PHARMACEUTICALS INC | $3.87 | 1.84% | 95.81% | -70.75% | $10.8M | 6.91% | — | HELD |
| 4 | TLYS | TILLYS INC | $5.45 | 2.64% | 373.91% | -60.85% | $8.7M | 5.59% | +2,150,000 | NEW |
| 5 | OM | OUTSET MED INC | $4.49 | 4.42% | -77.51% | -99.27% | $7.3M | 4.69% | +1,359,021 | +250.2% |
| 6 | PMVP | PMV PHARMACEUTICALS INC | $1.11 | 1.83% | 2.78% | -96.74% | $6.6M | 4.24% | +28,000 | +0.5% |
| 7 | KMX | CARMAX INC | $51.26 | -0.60% | -21.03% | -61.73% | $6.4M | 4.14% | — | HELD |
| 8 | 2KZ0 | KEZAR LIFE SCIENCES INC | — | — | — | — | $5.3M | 3.43% | — | HELD |
| 9 | TIL | INSTIL BIO INC | $7.92 | -0.13% | -76.86% | -97.37% | $5.3M | 3.42% | — | HELD |
| 10 | TGT | TARGET CORP | $135.23 | 1.95% | 48.00% | -39.72% | $4.5M | 2.92% | — | HELD |
| 11 | KHC | KRAFT HEINZ CO | $24.39 | 0.70% | -0.21% | -18.78% | $2.8M | 1.80% | +125,000 | NEW |
| 12 | JANX | JANUX THERAPEUTICS INC | $13.56 | -0.73% | -45.54% | -58.19% | $2.2M | 1.38% | +154,961 | NEW |
| 13 | PLRX | PLIANT THERAPEUTICS INC | $1.13 | -0.88% | -18.12% | -94.41% | $1.9M | 1.25% | — | HELD |
| 14 | CNTB | CONNECT BIOPHARMA HLDGS LTD | $2.12 | 0.95% | 123.16% | -90.37% | $1.1M | 0.69% | — | HELD |
| 15 | IMA | IMAGENEBIO INC | $5.62 | -1.58% | -65.31% | -95.27% | $1.0M | 0.64% | +23,704 | +13.4% |
| 16 | WMT | WALMART INC | $121.04 | 0.45% | 29.24% | 171.52% | $329K | 0.21% | — | HELD |
| 17 | CVNA | CARVANA CO | $64.10 | -5.49% | 7.90% | -5.05% | — | — | −150 | EXITED |
| 18 | TSLA | TESLA INC | $406.43 | 1.82% | 24.94% | 77.43% | — | — | −1,000 | EXITED |
| 19 | LSTA | LISATA THERAPEUTICS INC | $3.56 | 2.30% | 42.40% | -82.16% | — | — | −73,348 | EXITED |
Source: SEC EDGAR · accession 0001754960-26-000359. 13F discloses long positions only — shorts, foreign equities, and options are excluded.